国浩律师（上海）事务所 法律意见书 国浩律师（上海）事务所 关于安徽广信农化股份有限公司 2025 年第一次临时股东大会的 法律意见书 致：安徽广信农化股份有限公司 国浩律师（上海）事务所（以下简称"本所"）接受安徽广信农化股份有限 公司（以下简称"公司"）委托，指派律师出席并见证了公司于2025年9月4日在 广信股份总部大楼3楼会议室召开的公司2025年第一次临时股东大会（以下简称 "本次股东大会"），并根据《中华人民共和国公司法》《中华人民共和国证券法》 《上市公司股东大会规则》等法律、法规、规范性文件及《安徽广信农化股份有 限公司章程》（以下简称"公司章程"）的相关规定，出具本法律意见书。 一、本次股东大会的召集、召开程序 公司董事会于2025年8月19日召开第六届董事会第五次会议，审议通过了《关 于召开2025年第一次临时股东大会具体安排的议案》，并于2025年8月20日公告发 出了召开本次股东大会的会议通知。经核查，通知载明了会议的时间、地点、内 容、会议出席对象、网络投票的方法及时间，并说明了出席会议的股东登记方法、 联系方式等事项。 公司本次股东大会现场会议于2025年9月4日14:00在广信股 ...

证券代码：603599 证券简称：广信股份 公告编号：2025-025 安徽广信农化股份有限公司 2025年第一次临时股东大会决议公告 (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 316 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 488,056,744 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 53.6167 | 本次股东大会由董事长黄金祥先生主持，会议采用现场投票与网络投票相结 合的表决方式，大会的通知、召开、表决方式符合《公司法》及《公司章程》的 规定。 (五)公司董事、董事会秘书的出席情况 一、 会议召开和出席情况 (一)股东大会召开的时间：2025 年 9 月 4 日 (二)股东大会召开的地点 ...

Group 1 - The report highlights that SAIC Motor Corporation achieved a total revenue of 299.59 billion yuan in H1 2025, representing a year-on-year increase of 5.2%, while the net profit attributable to shareholders was 6.02 billion yuan, a decrease of 9.2% [4][5] - The company reported a significant increase in non-recurring net profit, which reached 5.43 billion yuan, up 432.2% year-on-year, indicating strong operational performance despite challenges [4][5] - The sales volume of SAIC Motor's vehicles in H1 2025 was 2.053 million units, an increase of 12.4% year-on-year, with a notable 40.2% increase in new energy vehicle sales [5][6] Group 2 - Shenzhou Taiyue's H1 2025 revenue was 2.685 billion yuan, down 12.05% year-on-year, with a net profit of 509 million yuan, reflecting a decline of 19.26% [11][12] - The gaming segment contributed 75.53% of total revenue, with a significant drop in revenue from major titles, indicating a need for new product launches to drive growth [12][13] - The company is expected to enter a three-year product cycle from 2025 to 2027, with multiple new games set to launch, which could enhance revenue streams [12][14] Group 3 - Lemon Film's H1 2025 revenue reached 401 million yuan, a remarkable increase of 108.5% year-on-year, with a net profit of 10.82 million yuan, compared to a loss in the previous year [17][18] - The growth was driven by overseas distribution and short drama business expansion, alongside effective cost control measures [18][19] - The company is positioned as a leader in the long drama industry, with strong content production capabilities and a focus on overseas and short drama markets [21][22] Group 4 - Jinshi Resources reported a revenue of 1.726 billion yuan in H1 2025, a year-on-year increase of 54.24%, primarily due to the release of production capacity in fluorochemical products [23][24] - The company faced a net profit decline of 24.74% due to operational challenges and increased costs associated with mining projects [24][25] - The strategic shift towards global resource integration is expected to yield long-term benefits, with projected revenues of 3.727 billion yuan in 2025 [27][28] Group 5 - Zhongke Chuangda's H1 2025 revenue was 3.299 billion yuan, up 37.44% year-on-year, with a net profit of 158 million yuan, reflecting a growth of 51.84% [29][30] - The smart IoT business saw a remarkable growth of 136%, becoming the fastest-growing segment, while the smart automotive and software businesses maintained steady expansion [30][31] - The company is expected to continue leading in the edge AI sector, with projected revenues of 6.533 billion yuan by 2027 [35] Group 6 - Sound Group Inc. achieved a total revenue of 1.358 billion yuan in H1 2025, a 46.9% increase year-on-year, with a net profit of 68 million yuan, marking a turnaround from losses [39][42] - The audio entertainment segment remains the core revenue driver, while AI-related services are expected to enhance growth potential [39][40] - The company is focusing on user engagement and content creation to improve monetization and user retention [41][42] Group 7 - Beautiful Field Medical Health reported a revenue of 1.459 billion yuan in H1 2025, a 28.2% increase year-on-year, with a net profit of 171 million yuan, reflecting a growth of 35.5% [44][45] - The growth was driven by an increase in active members and the expansion of health services, particularly in the sub-health sector [45][46] - The company is expected to maintain a strong growth trajectory, with projected revenues of 3 billion yuan by 2027 [46]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][18]. Core Views - The company's performance in Q2 2025 showed stabilization year-on-year, with a gradual recovery in pesticide demand [3][7]. - The company achieved a revenue of 1.89 billion yuan in H1 2025, a year-on-year decrease of 17.4%, and a net profit attributable to shareholders of 350 million yuan, down 15.0% year-on-year [7]. - In Q2 2025, the company reported a revenue of 910 million yuan, a year-on-year decline of 15.3%, but a net profit of 190 million yuan, which is an increase of 1.4% year-on-year [7]. - The company has effectively utilized its resources to achieve cost reduction and efficiency improvement, contributing to the stabilization of its performance despite a decline in pesticide raw material sales [7]. Financial Performance - The company's gross profit margin in H1 2025 was 30.7%, a decrease of 0.5 percentage points year-on-year, while the net profit margin increased by 0.7 percentage points to 18.6% [7]. - In Q2 2025, the gross profit margin was 30.9%, an increase of 0.6 percentage points year-on-year, and the net profit margin was 20.9%, up 3.4 percentage points year-on-year [7]. - The main pesticide raw materials generated a revenue of 420 million yuan in Q2 2025, down 18% year-on-year, with a sales volume of 14,000 tons, down 22% year-on-year [7]. Market Outlook - The company is expected to achieve revenues of 4.8 billion yuan, 5.8 billion yuan, and 6.9 billion yuan in 2025, 2026, and 2027 respectively, with net profits of 826 million yuan, 1.017 billion yuan, and 1.186 billion yuan [7][10]. - The company maintains a strong cash position and has significant expansion capabilities in the future, supported by its integrated industry chain advantages [7].

Group 1 - The report highlights the focus on capital flows and corporate profit improvement, indicating a positive trend in the domestic equity market compared to global assets [6][8] - The report notes that in the first half of 2025, the total revenue of listed companies in A-shares grew by 0.02% year-on-year, while the net profit attributable to shareholders increased by 2.45%, suggesting better profit improvement than revenue growth [8][10] - The report emphasizes the strong performance of Baipusais (301080), with a revenue of 387 million yuan in H1 2025, representing a year-on-year increase of 29.38%, and a net profit of 83.8 million yuan, up 47.81% [11][12] Group 2 - Tongkun Co., Ltd. (601233) reported a slight increase in performance, with total revenue of 44.158 billion yuan in H1 2025, a year-on-year decrease of 8.41%, while net profit attributable to shareholders was 1.097 billion yuan, up 2.93% [15][16] - Rongchang Bio (688331) achieved a revenue of 1.098 billion yuan in H1 2025, reflecting a year-on-year growth of 48.02%, although it still reported a net loss of 450 million yuan [19][20] - Guangxin Co., Ltd. (603599) experienced a decline in revenue to 1.890 billion yuan in H1 2025, down 17.36% year-on-year, with a net profit of 351 million yuan, a decrease of 14.95% [23][24] Group 3 - The report indicates that the agricultural pesticide industry is expected to improve due to various policies, with a significant reduction in inventory levels for Guangxin Co., Ltd. [25][26] - The report suggests that the domestic market for long silk is expected to improve, with a focus on the upcoming peak season in September and October [17][18] - The report projects that Baipusais will achieve revenues of 799 million yuan, 966 million yuan, and 1.148 billion yuan from 2025 to 2027, with corresponding net profits of 166 million yuan, 208 million yuan, and 252 million yuan [11][12]

Core Viewpoint - Since March 2025, glyphosate prices have been steadily rising, with a significant acceleration in the upward trend since May, reaching approximately 27,300 yuan/ton by the end of August, a 24% increase from the year's low [1][2] Price Trends - Glyphosate prices have been rebounding since March, primarily due to a "de-involution" meeting held on March 13 and the CAC Agricultural Chemicals Expo starting on March 17, leading to coordinated production cuts among manufacturers [2] - The price increase has been further supported by improved demand, particularly from South America, with China's exports of non-halogenated organic phosphorus derivatives reaching 391,000 tons in the first seven months of 2025, a year-on-year increase of 12% [2] Industry Profitability - The profitability of glyphosate companies has significantly improved, with the price reaching 27,300 yuan/ton as of August 29, resulting in a price difference of approximately 13,600 yuan/ton for the glycine method, up from about 9,000 yuan/ton in March [3] Future Price Outlook - Glyphosate prices are expected to rise to 30,000 yuan/ton in Q4 2025, driven by high demand as the North American peak season begins in October and limited new supply due to construction delays [4] Recommended Stocks - Companies that are expected to benefit from the price elasticity of glyphosate include Xingfa Group (600141.SH), Jiangshan Chemical (600389.SH), Xin'an Chemical (600596.SH), Yangnong Chemical (600486.SH), and Guangxin Co., Ltd. (603599.SH) [5]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company's performance in the first half of 2025 is under short-term pressure, but the pesticide industry is expected to improve [1] - The company reported a revenue of 1.89 billion yuan in H1 2025, a year-on-year decrease of 17.36%, and a net profit attributable to shareholders of 351 million yuan, down 14.95% year-on-year [5] - The company has optimized inventory management, significantly reducing inventory to 430 million yuan, which accounts for 2.86% of total assets, a year-on-year decrease of 51.14% [5] - The company is expanding its product chain by leveraging phosgene resources, enhancing its competitive advantage in the market [5] Summary by Sections Financial Performance - In H1 2025, the company achieved total revenue of 1.89 billion yuan, down 17.36% year-on-year, and a net profit of 351 million yuan, down 14.95% year-on-year [5] - The sales expenses increased by 50.41% to 34.98 million yuan, while management expenses decreased by 18.99% to 159 million yuan [5] - R&D expenses decreased by 40.75% to 93.25 million yuan [5] Revenue and Profit Forecast - The forecast for total revenue from 2025 to 2027 is adjusted to 4.701 billion yuan, 5.731 billion yuan, and 6.282 billion yuan respectively [5] - The net profit attributable to shareholders is forecasted to be 837 million yuan, 1.095 billion yuan, and 1.164 billion yuan for the same period [5] - The corresponding EPS for these years is projected to be 0.92 yuan, 1.20 yuan, and 1.28 yuan [5] Market and Industry Outlook - The pesticide industry is expected to see improvements due to various policies aimed at enhancing regulation and reducing illegal production [5] - The company is focusing on extending its product chain into fine chemicals, pesticides, and pharmaceutical intermediates, which is expected to optimize production costs [5]

Group 1 - The core viewpoint of the article highlights the recent stock performance of Guangxin Co., which saw a decline of 4.11% on August 27, closing at 12.12 yuan, with a trading volume of 177,971 hands and a turnover of 220 million yuan [1] - Guangxin Co. specializes in the research, production, and sales of pesticide raw materials and formulations, with key products including glyphosate and diuron, and is one of the major domestic producers of glyphosate with an annual production capacity of 60,000 tons [1] - The glyphosate market is currently experiencing a tight supply-demand situation, with prices for 95% glyphosate quoted at 27,500 yuan per ton and 97% glyphosate at 28,000 yuan per ton, reflecting a 20% increase since early May [1] Group 2 - On August 27, Guangxin Co. experienced a net outflow of main funds amounting to 2.5156 million yuan, representing 0.02% of its circulating market value, while over the past five days, there was a net inflow of 10.9366 million yuan, accounting for 0.1% of its circulating market value [1] - Despite an increase in production, glyphosate inventory continues to decline, indicating a sustained tight supply situation in the current market [1]

Group 1 - The agricultural chemical sector increased by 2.34% on August 26, with Bai'ao Chemical leading the gains [1] - The Shanghai Composite Index closed at 3868.38, down 0.39%, while the Shenzhen Component Index closed at 12473.17, up 0.26% [1] - Bai'ao Chemical's stock price rose by 10.02% to 23.16, with a trading volume of 321,000 shares and a transaction value of 718 million [1] Group 2 - The agricultural chemical sector experienced a net outflow of 78.12 million from main funds, while retail funds saw a net outflow of 91.58 million [2] - The main funds net inflow for Bai'ao Chemical was 15.4 million, accounting for 21.41% of its trading volume [3] - Cloud Map Holdings had a main funds net inflow of 5.2 million, representing 4.58% of its trading volume [3]

Group 1 - The China Securities Agricultural and Animal Husbandry Theme Index (931778) increased by 2.41%, with notable stock performances including Muyuan Foods (002714) up 7.51%, Tiankang Bio (002100) up 6.04%, and Jiangshan Co. (600389) up 5.74% [1] - Recent policies aimed at regulating the pig farming industry have been intensively released, including a proposal from the National Development and Reform Commission in early June to not increase production capacity and to stabilize prices, followed by a meeting in late July where the Ministry of Agriculture urged core enterprises to strictly implement capacity control measures [1] - On August 13, an industry association meeting advocated for reducing production capacity to 39.5 million pigs, with several leading enterprises responding positively to the capacity control policies, indicating a reduction in the breeding sow inventory [1] - Despite continued profitability in fattening and breeding segments, the ongoing implementation of anti-involution policies and the need to mitigate pandemic risks are expected to lead to a reduction in industry capacity [1] - Glyphosate prices have rebounded from a low point, with some product demand recovering; from Q3 2025, the average market price of glyphosate increased by 11.2% compared to Q2 [1] - The pesticide industry shows rigid demand but is currently at the bottom of the industry cycle, characterized by "increased volume but reduced profits," with ongoing destocking bringing global pesticide channel inventory closer to reasonable levels [1] Group 2 - The China Construction Bank China Securities Agricultural and Animal Husbandry Theme ETF (159616) closely tracks the China Securities Agricultural and Animal Husbandry Theme Index, which selects 50 listed companies involved in grain planting, seed production, pesticide and fertilizer, agricultural machinery, livestock farming, feed production, and animal health [2]